Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,342 | 14,764 | 17,219 | 14,778 | 16,665 |
| Receivables | 130,548 | 120,755 | 114,894 | 122,645 | 130,207 |
| Inventories | 37,537 | 33,720 | 37,339 | 39,818 | 41,702 |
| Other current assets | 6,303 | 6,511 | 6,931 | 6,832 | 6,645 |
| TOTAL | $200,981 | $186,461 | $185,354 | $194,985 | $207,410 |
| Non-Current Assets | |||||
| PPE Net | 127,728 | 129,882 | 131,210 | 135,060 | 138,860 |
| Intangibles | 188,857 | 188,980 | 189,063 | 187,859 | 188,016 |
| Other Non-Current Assets | 62,850 | 67,729 | 56,511 | 54,202 | 52,964 |
| TOTAL | $379,435 | $386,591 | $376,784 | $377,121 | $379,840 |
| Total Assets | $580,416 | $573,052 | $562,138 | $572,106 | $587,250 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 36,477 | 33,720 | 32,201 | 29,404 | 34,753 |
| Accrued Expenses | 24,986 | 19,411 | 23,541 | 34,512 | 34,756 |
| Other current liabilities | 10,229 | 13,668 | 12,398 | 13,119 | 12,388 |
| TOTAL | $108,797 | $104,023 | $93,542 | $96,215 | $108,416 |
| Non-Current Liabilities | |||||
| Long Term Debt | 218,613 | 216,488 | 206,363 | 208,237 | 407,112 |
| Deferred Revenues | 19,300 | 15,690 | 12,990 | 11,114 | 14,272 |
| Other Non-Current Liabilities | 92,166 | 91,057 | 93,469 | 92,810 | 91,686 |
| TOTAL | $318,272 | $313,732 | $305,799 | $308,940 | $506,816 |
| Total Liabilities | $427,069 | $417,755 | $399,341 | $405,155 | $615,232 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,183 | 44,152 | 44,110 | 44,106 | 42,399 |
| Common Shares | 1,148 | 1,148 | 1,148 | 1,180 | 1,142 |
| Retained earnings | 181,247 | 187,957 | 196,760 | 204,287 | 210,983 |
| Other shareholders' equity | -5,488 | -5,658 | -5,590 | -6,893 | -5,463 |
| TOTAL | $153,347 | $155,297 | $162,797 | $166,951 | $-27,982 |
| Total Liabilities And Equity | $580,416 | $573,052 | $562,138 | $572,106 | $587,250 |